Minerva Biotechnologies

BS/MS Level Scientist Position
Immediate openings for BS or MS level scientists to work in the exciting new field of cancer immunotherapy. Collaborative, team-oriented culture. Background in Biology, Biochemistry, Biotech, or Immunohistochemistry is desirable. Applicants with strong technical skills such as experience with cancer cell culture, flow cytometry, immunohistochemistry, ELISA and/or animal work are sought but will train motivated individuals. Candidate must have excellent work ethic and ability to work independently as well as part of a team. Competitive salaries and stock option packages. Waltham, MA location is convenient to major highways. We are only limited by our own imaginations. Join us and change the world.
Please send a brief cover letter and CV to [email protected]

Join us for our poster "1st-In-Human CAR T Targets MUC1 Transmembrane Cleavage Product" at virtual . Dr. Cynthia Bamdad will be online from 5:30-6:30 today. Poster is #757.

2020 Annual Meeting | ASGCT 2020 We hope you're getting excited for the start of the ASGCT 23rd Annual Meeting tomorrow! As a registered attendee, here's how to access the virtual meeting environment.

https://www.businesswire.com/news/home/20190624005121/en/Minerva-Biotechnologies-Announces-FDA-Acceptance-IND-Application

Minerva Biotechnologies Announces FDA Acceptance of IND Application for huMNC2-CAR44 T cells to Treat Metastatic Breast Cancer Minerva Biotechnologies reports the FDA has approved their IND application to conduct clinical trials in breast cancer with their MUC1* CAR T cells.